Found: 11
Select item for more details and to access through your institution.
Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.
- Published in:
- International Journal of Clinical Pharmacology & Therapeutics, 2014, v. 52, n. 1, p. 76, doi. 10.5414/CPXCES13EA02
- By:
- Publication type:
- Article
Toll-Like Receptor 4 Engagement Drives Differentiation of Human and Murine Dendritic Cells from a Pro- into an Anti-Inflammatory Mode.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0054879
- By:
- Publication type:
- Article
Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 8, p. 769, doi. 10.1007/s00262-004-0637-2
- By:
- Publication type:
- Article
Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 67, doi. 10.1007/s00262-004-0571-3
- By:
- Publication type:
- Article
Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables.
- Published in:
- Acta Neuropathologica Communications, 2018, v. 6, n. 1, p. N.PAG, doi. 10.1186/s40478-018-0621-2
- By:
- Publication type:
- Article
MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1579, doi. 10.3390/cancers14061579
- By:
- Publication type:
- Article
CD40 ligation restores type 1 polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12 expression.
- Published in:
- Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 8b, p. 1741, doi. 10.1111/j.1582-4934.2008.00584.x
- By:
- Publication type:
- Article
Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines.
- Published in:
- Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 1, p. 125, doi. 10.1111/j.1582-4934.2008.00304.x
- By:
- Publication type:
- Article
Leukemia-associated antigenic isoforms induce a specific immune response in children with T-ALL.
- Published in:
- International Journal of Cancer, 2006, v. 119, n. 12, p. 2870, doi. 10.1002/ijc.22224
- By:
- Publication type:
- Article
Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. 1, doi. 10.1038/s41541-019-0149-x
- By:
- Publication type:
- Article
Immunophenotypic characterization of myelomonocytic cells in patients with myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 1993, v. 84, n. 3, p. 428, doi. 10.1111/j.1365-2141.1993.tb03097.x
- By:
- Publication type:
- Article